Navigation Links
OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
Date:6/22/2011

SAN DIEGO, June 22, 2011 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), a therapeutic oncology company developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that Anthony E Maida, III, Ph.D., has been appointed to OncoSec's board of directors and will chair its audit committee.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

For over 20 years, Dr. Maida has focused on clinical development of immunotherapies to treat patients with cancer. As a Chairman, CEO and senior executive, Dr. Maida has managed and executed all critical functions, including finance, operations, research, clinical development, regulatory and manufacturing for biotechnology companies in early and late-stage development of cancer therapeutics. In addition, he has negotiated significant license agreements with numerous global pharmaceutical firms and major universities. Dr. Maida has also raised or assisted in financings of nearly $200 million for start-up and emerging biotechnology companies.

Dr. Maida stated, "OncoSec's novel approaches to addressing the challenge of treating solid tumors in a manner that is less invasive are very promising. I'm pleased to be able to offer my experience to OncoSec at a time when they are moving their oncology therapies into advanced clinical trials."

Punit Dhillon, OncoSec's President and CEO, said, "Dr. Maida's expertise could not be a better fit for OncoSec, its technology platform, and its development plans. We look forward to the critical input, guidance and resources he will be able to contribute to OncoSec and its shareholders."

Dr. Maida was recently Vice President of Clinical Research and General Manager, Oncology, World-wide, for a leading international contract research organization. Prior to this, Dr. Maida served as Chairman, Founder and Director of BioConsul Drug Develo
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
4. OncoSec Medical Closes $1.1M Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... The study finds that the majority of ...
(Date:7/29/2014)... Conn. , July 29, 2014 Numotion,s Board ... Mike Swinford will be the company,s new Chief ... highly successful 22-year career at GE where he worked primarily ... in annual revenue to over $5 billion. His most recent ... Services. "I am thrilled to join Numotion," ...
(Date:7/29/2014)... 2014  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched ... (AACC) 2014 Clinical Lab Expo today by unveiling two ... Roche is partnering with customers to redefine the value ... every day that they,re looking for a partner to ... labs and offices," said Jack Phillips , president ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Numotion Names Mike Swinford CEO 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... Calif., June 2, 2011 Clovis Oncology, Inc. and ... they have entered into an agreement to develop an ... companion diagnostic test. The goal is to identify activating ... non-small cell lung cancer (NSCLC), including the EGFR T790M ...
... /PRNewswire-iReach/ -- The Institute for ... of gluten-free food supplements and herbs.The Institute for ... for integrative rheumatology—has launched GLUTEN-FREE REMEDIES™, a line ... a new standard of quality. Selected for the ...
Cached Medicine Technology:Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic 2Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic 3The Institute for Specialized Medicine Launches GLUTEN-FREE REMEDIES, a New Line of Gluten-free Food Supplements and Herbs. 2
(Date:7/30/2014)... The San Diego personal injury lawyers of ... that they are now offering free case reviews for individuals ... exposure. , “Symptoms of asbestos exposure can take years to ... plus years ago may just now be suffering from the ... of Melinda J. Helbock A.P.C. “We want people to know ...
(Date:7/29/2014)... VisitandCare.com today announced that ... to the company’s exclusive network to help couples struggling ... efforts — as top fertility clinics in Spain, Switzerland, ... state-of-the-art, and successful IVF treatments. , The exclusive selection ... study by professionals at VisitandCare.com. The goal is to ...
(Date:7/29/2014)... 2014 1Heart Caregiver Services’ advocacy ... focus on Brain Fitness Education brings great acceptance ... Fitness Program Director Tee Barr delivered an exceptional ... unit and the Assisted Living section of Aegis ... Director Christy Rozsa and Aegis Life Neighborhood Director ...
(Date:7/29/2014)... chemical alteration in a single human gene linked to ... give doctors a simple blood test to reliably predict ... described online in The American Journal of Psychiatry ... the function of the brain,s response to stress hormones ... be an unremarkable reaction to the strain of everyday ...
(Date:7/29/2014)... Diabetes is a common condition diagnosed in ... levels are increased, while the production of insulin is decreased. ... and which is needed by the body to regulate blood ... be very dangerous, as there are numerous complications that can ... this disorder and read a complex review of Matt Traverso's ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Reverse Your Diabetes Today Review Exposes Matt Traverso’s New eBook 2
... Looking for a unique, customized gift,for the animal lover ... Morris Animal Foundation (MAF) that benefits a favorite animal,-- dog, ... special gift for,anyone on your list. Many people who make ... notation in their holiday cards. A donation can be a,wonderful ...
... the body , , TUESDAY, Nov. 11 (HealthDay News) -- ... of high blood pressure in women who currently have ... new study by U.S. researchers who analyzed data from ... Lipoprotein particles carry cholesterol and triglycerides throughout the body. ...
... Chief Marketing,Executive at Online Buddies Inc., the parent ... of the Centers for Disease Control and Prevention,(CDC) ... as the site,s first Senior,Public Health Strategist. MANHUNT, ... 2,000,000 members worldwide, is the first social networking,site ...
... PRAIRIE, Minn., Nov. 11 Pam Kreager, ... Prairie, Minnesota-based Long Term,Care Group, Inc. (LTCG), ... Term Care,International Forum (LTCIF). The Long Term ... organization whose purpose is to promote,efficiency, effectiveness ...
... press release is available in French . ... created a new protein patterning technique that,s enabled them ... of a masterpiece painting. According to a new study ... from Universit de Montral, the Maisonneuve-Rosemont Hospital Research Centre, ...
... at the Yerkes National Primate Research Center, Emory University, ... and generation of several types of neural cells. Findings ... the journal Stem Cells , suggest dental pulp ... and regenerative medicine, particularly therapies associated with the central ...
Cached Medicine News:Health News:Unique Holiday Gift for Animal Lovers: A Donation to Fund Animal Health Research; Pick a Favorite Animal - Dog, Cat, Horse, All Species of Wildlife 2Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2Health News:Long Term Care International Forum names LTCG's Pam Kreager as President 2Health News:New laser method reproduces art masterworks to protein patterns 2
... Prep Swabsticks are saturated with a 10% ... available iodine. Povidone Iodine is virtually non-irritating ... is also non-staining to the skin or ... microbes on contact; they are sturdy tools ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks....
... Swabsticks are packaged in easy open, single-use ... saturated with precisely the correct amount of ... the safest possible product for the patient. ... an excellent combination of ethyl alcohol and ...
Medicine Products: